Research Article

Formulation, Optimization, and In-Vitro Evaluation of Hyaluronic Acid Buccal Films Containing Benzydamine Hydrochloride

Volume: 11 Number: 3 September 20, 2021
EN TR

Formulation, Optimization, and In-Vitro Evaluation of Hyaluronic Acid Buccal Films Containing Benzydamine Hydrochloride

Abstract

Aim: Mucoadhesive buccal films provide drug delivery for both local and systemic circulation with increased patient compliance. The objective of this study was to develop a buccal film containing benzydamine hydrochloride (BNZ) by using hyaluronic acid (HA) as a film-forming agent and glycerin (Gly) as a plasticizer for the anti-inflammatory effect on the mucosal ulcer. Material and Methods: The effects of different concentrations of HA and Gly on responses were analyzed using 23 factorial design. The HA and Gly ratio were selected as independent factors, and work of mucoadhesion, tensile strength, elongation at break, and contact angle values were chosen as dependent factors. Nine different film formulations were prepared at constant BNZ concentration (0.15%) by solvent casting method. Mechanical and mucoadhesion properties of film formulations were evaluated, and also contact angles were calculated. The BNZ release profiles were evaluated in simulated saliva solution (pH 6.8). Results: All film formulations were successfully prepared by solvent casting method. Increasing HA concentration from 0.5 to 2 % raised the mechanical and mucoadhesion properties of film formulations. Although the addition of Gly decreased the tensile strength values, it increased the elongation at break values about ten times. All formulations released more than 60 % BNZ in 60 mins. Conclusion: It is concluded that HA oral mucoadhesive film formulations containing BNZ are promising for treating oral ulcers.

Keywords

References

  1. Alves TFR, Rios AC, Pontes K da S, Portella DL, Aranha N, Severino P, et al. Bilayer mucoadhesive buccal film for mucosal ulcers treatment: development, characterization, and single study case. Pharmaceutics. 2020; 12(7): 1-24.
  2. Yaprak Karavana S, Güneri P, Ertan G. Benzydamine hydrochloride buccal bioadhesive gels designed for oral ulcers: preparation, rheological, textural, mucoadhesive and release properties. Pharm Dev Technol. 2009; 14(6): 623-31.
  3. Pechova V, Gajdziok J, Muselik J, Vetchy D. Development of orodispersible films containing benzydamine hydrochloride using a modified solvent casting method. AAPS Pharm Sci Tech. 2018; 19(6): 2509-18.
  4. Borges AF, Silva C, Coelho JFJ, Simoes S. Oral films: Current status and future perspectives: I-galenical development and quality attributes. J Control Release. 2015; 206: 1-19.
  5. Semalty M, Semalty A, Kumar G. Formulation and characterization of mucoadhesive buccal films of glipizide. Indian J Pharm Sci. 2008; 70(1): 43-8.
  6. Nappinnai M, Chandanbala R, Balaijirajan R. Formulation and evaluation of nitrendipine buccal films. Indian J Pharm Sci. 2008; 70(5): 631-5.
  7. Preis M, Knop K, Breitkreutz J. Mechanical strength test for orodispersible and buccal films. Int J Pharm. 2014; 461(1-2): 22-9.
  8. Mahajan A, Chhabra N, Aggarwal G. Formulation and characterization of fast dissolving buccal films: a review. Der Pharm Lett. 2011; 3(1): 152-65.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

September 20, 2021

Submission Date

November 28, 2020

Acceptance Date

May 15, 2021

Published in Issue

Year 2021 Volume: 11 Number: 3

APA
Karaküçük, A., & Tort, S. (2021). Formulation, Optimization, and In-Vitro Evaluation of Hyaluronic Acid Buccal Films Containing Benzydamine Hydrochloride. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 11(3), 325-330. https://doi.org/10.33631/duzcesbed.833024
AMA
1.Karaküçük A, Tort S. Formulation, Optimization, and In-Vitro Evaluation of Hyaluronic Acid Buccal Films Containing Benzydamine Hydrochloride. J DU Health Sci Inst. 2021;11(3):325-330. doi:10.33631/duzcesbed.833024
Chicago
Karaküçük, Alptuğ, and Serdar Tort. 2021. “Formulation, Optimization, and In-Vitro Evaluation of Hyaluronic Acid Buccal Films Containing Benzydamine Hydrochloride”. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 11 (3): 325-30. https://doi.org/10.33631/duzcesbed.833024.
EndNote
Karaküçük A, Tort S (September 1, 2021) Formulation, Optimization, and In-Vitro Evaluation of Hyaluronic Acid Buccal Films Containing Benzydamine Hydrochloride. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 11 3 325–330.
IEEE
[1]A. Karaküçük and S. Tort, “Formulation, Optimization, and In-Vitro Evaluation of Hyaluronic Acid Buccal Films Containing Benzydamine Hydrochloride”, J DU Health Sci Inst, vol. 11, no. 3, pp. 325–330, Sept. 2021, doi: 10.33631/duzcesbed.833024.
ISNAD
Karaküçük, Alptuğ - Tort, Serdar. “Formulation, Optimization, and In-Vitro Evaluation of Hyaluronic Acid Buccal Films Containing Benzydamine Hydrochloride”. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 11/3 (September 1, 2021): 325-330. https://doi.org/10.33631/duzcesbed.833024.
JAMA
1.Karaküçük A, Tort S. Formulation, Optimization, and In-Vitro Evaluation of Hyaluronic Acid Buccal Films Containing Benzydamine Hydrochloride. J DU Health Sci Inst. 2021;11:325–330.
MLA
Karaküçük, Alptuğ, and Serdar Tort. “Formulation, Optimization, and In-Vitro Evaluation of Hyaluronic Acid Buccal Films Containing Benzydamine Hydrochloride”. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, vol. 11, no. 3, Sept. 2021, pp. 325-30, doi:10.33631/duzcesbed.833024.
Vancouver
1.Alptuğ Karaküçük, Serdar Tort. Formulation, Optimization, and In-Vitro Evaluation of Hyaluronic Acid Buccal Films Containing Benzydamine Hydrochloride. J DU Health Sci Inst. 2021 Sep. 1;11(3):325-30. doi:10.33631/duzcesbed.833024

Cited By